Research analysts at StockNews.com assumed coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) in a report issued on Saturday. The firm set a “sell” rating on the basic materials company’s stock.
Separately, HC Wainwright reissued a “buy” rating and set a $6.00 price target on shares of Arcadia Biosciences in a report on Wednesday, August 21st.
View Our Latest Stock Analysis on RKDA
Arcadia Biosciences Stock Performance
Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) last issued its quarterly earnings results on Tuesday, August 13th. The basic materials company reported $0.78 earnings per share for the quarter, missing analysts’ consensus estimates of $1.27 by ($0.49). The firm had revenue of $1.31 million for the quarter, compared to the consensus estimate of $0.95 million. Arcadia Biosciences had a negative return on equity of 57.51% and a negative net margin of 127.29%. During the same period last year, the company posted ($2.64) EPS. Equities research analysts forecast that Arcadia Biosciences will post -1.7 earnings per share for the current year.
About Arcadia Biosciences
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
See Also
- Five stocks we like better than Arcadia Biosciences
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- The How And Why of Investing in Oil Stocks
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What Are Dividends? Buy the Best Dividend Stocks
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.